Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.

Goo L, Debbink K, Kose N, Sapparapu G, Doyle MP, Wessel AW, Richner JM, Burgomaster KE, Larman BC, Dowd KA, Diamond MS, Crowe JE Jr, Pierson TC.

Nat Microbiol. 2019 Jan;4(1):71-77. doi: 10.1038/s41564-018-0283-7. Epub 2018 Nov 19.

2.

Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands.

Lindesmith LC, Brewer-Jensen PD, Mallory ML, Yount B, Collins MH, Debbink K, Graham RL, Baric RS.

J Virol. 2019 Jan 4;93(2). pii: e01813-18. doi: 10.1128/JVI.01813-18. Print 2019 Jan 15.

3.

Bat Caliciviruses and Human Noroviruses Are Antigenically Similar and Have Overlapping Histo-Blood Group Antigen Binding Profiles.

Kocher JF, Lindesmith LC, Debbink K, Beall A, Mallory ML, Yount BL, Graham RL, Huynh J, Gates JE, Donaldson EF, Baric RS.

MBio. 2018 May 22;9(3). pii: e00869-18. doi: 10.1128/mBio.00869-18.

4.

Ureteric transection secondary to penetrating handlebar injury.

Debbink KP, Tashjian DB, Tirabassi MV, Gaffey R, Nahmias J.

Trauma Case Rep. 2017 Jul 31;10:16-18. doi: 10.1016/j.tcr.2017.07.002. eCollection 2017 Aug.

5.

Conformational Occlusion of Blockade Antibody Epitopes, a Novel Mechanism of GII.4 Human Norovirus Immune Evasion.

Lindesmith LC, Mallory ML, Debbink K, Donaldson EF, Brewer-Jensen PD, Swann EW, Sheahan TP, Graham RL, Beltramello M, Corti D, Lanzavecchia A, Baric RS.

mSphere. 2018 Feb 7;3(1). pii: e00518-17. doi: 10.1128/mSphere.00518-17. eCollection 2018 Jan-Feb.

6.

Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape.

Lindesmith LC, Brewer-Jensen PD, Mallory ML, Debbink K, Swann EW, Vinjé J, Baric RS.

J Infect Dis. 2018 Mar 13;217(7):1145-1152. doi: 10.1093/infdis/jix651.

7.

Transplantation of a quaternary structure neutralizing antibody epitope from dengue virus serotype 3 into serotype 4.

Widman DG, Young E, Nivarthi U, Swanstrom JA, Royal SR, Yount BL, Debbink K, Begley M, Marcet S, Durbin A, de Silva AM, Messer WB, Baric RS.

Sci Rep. 2017 Dec 7;7(1):17169. doi: 10.1038/s41598-017-17355-5.

8.

Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis.

Menachery VD, Gralinski LE, Mitchell HD, Dinnon KH 3rd, Leist SR, Yount BL Jr, Graham RL, McAnarney ET, Stratton KG, Cockrell AS, Debbink K, Sims AC, Waters KM, Baric RS.

mSphere. 2017 Nov 15;2(6). pii: e00346-17. doi: 10.1128/mSphere.00346-17. eCollection 2017 Nov-Dec.

9.

Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.

Lindesmith LC, Kocher JF, Donaldson EF, Debbink K, Mallory ML, Swann EW, Brewer-Jensen PD, Baric RS.

J Infect Dis. 2017 Dec 5;216(10):1227-1234. doi: 10.1093/infdis/jix385.

10.

Further Evidence for Bats as the Evolutionary Source of Middle East Respiratory Syndrome Coronavirus.

Anthony SJ, Gilardi K, Menachery VD, Goldstein T, Ssebide B, Mbabazi R, Navarrete-Macias I, Liang E, Wells H, Hicks A, Petrosov A, Byarugaba DK, Debbink K, Dinnon KH, Scobey T, Randell SH, Yount BL, Cranfield M, Johnson CK, Baric RS, Lipkin WI, Mazet JA.

MBio. 2017 Apr 4;8(2). pii: e00373-17. doi: 10.1128/mBio.00373-17.

11.

Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses.

Debbink K, McCrone JT, Petrie JG, Truscon R, Johnson E, Mantlo EK, Monto AS, Lauring AS.

PLoS Pathog. 2017 Jan 31;13(1):e1006194. doi: 10.1371/journal.ppat.1006194. eCollection 2017 Jan.

12.

Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.

Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS.

Nat Med. 2016 Apr;22(4):446. doi: 10.1038/nm0416-446d. No abstract available.

PMID:
27050591
13.

SARS-like WIV1-CoV poised for human emergence.

Menachery VD, Yount BL Jr, Sims AC, Debbink K, Agnihothram SS, Gralinski LE, Graham RL, Scobey T, Plante JA, Royal SR, Swanstrom J, Sheahan TP, Pickles RJ, Corti D, Randell SH, Lanzavecchia A, Marasco WA, Baric RS.

Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53. doi: 10.1073/pnas.1517719113. Epub 2016 Mar 14.

14.

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.

Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS.

Nat Med. 2015 Dec;21(12):1508-13. doi: 10.1038/nm.3985. Epub 2015 Nov 9. Erratum in: Nat Med. 2016 Apr;22(4):446.

15.

Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.

Lindesmith LC, Ferris MT, Mullan CW, Ferreira J, Debbink K, Swanstrom J, Richardson C, Goodwin RR, Baehner F, Mendelman PM, Bargatze RF, Baric RS.

PLoS Med. 2015 Mar 24;12(3):e1001807. doi: 10.1371/journal.pmed.1001807. eCollection 2015 Mar.

16.

Editorial commentary: Ancestry-based differences in norovirus susceptibility: implications for understanding global infection patterns.

Debbink K.

Clin Infect Dis. 2015 Jun 1;60(11):1639-41. doi: 10.1093/cid/civ168. Epub 2015 Mar 5. No abstract available.

17.

Coronavirus non-structural protein 16: evasion, attenuation, and possible treatments.

Menachery VD, Debbink K, Baric RS.

Virus Res. 2014 Dec 19;194:191-9. doi: 10.1016/j.virusres.2014.09.009. Epub 2014 Sep 30. Review.

18.

Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope.

Lindesmith LC, Donaldson EF, Beltramello M, Pintus S, Corti D, Swanstrom J, Debbink K, Jones TA, Lanzavecchia A, Baric RS.

J Virol. 2014 Aug;88(16):8826-42. doi: 10.1128/JVI.01192-14. Epub 2014 May 28.

19.

Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.

Debbink K, Lindesmith LC, Donaldson EF, Swanstrom J, Baric RS.

J Virol. 2014 Jul;88(13):7256-66. doi: 10.1128/JVI.00785-14. Epub 2014 Apr 16.

20.

Within-host evolution results in antigenically distinct GII.4 noroviruses.

Debbink K, Lindesmith LC, Ferris MT, Swanstrom J, Beltramello M, Corti D, Lanzavecchia A, Baric RS.

J Virol. 2014 Jul;88(13):7244-55. doi: 10.1128/JVI.00203-14. Epub 2014 Mar 19.

21.

The state of norovirus vaccines.

Debbink K, Lindesmith LC, Baric RS.

Clin Infect Dis. 2014 Jun;58(12):1746-52. doi: 10.1093/cid/ciu120. Epub 2014 Feb 27.

22.

Human norovirus detection and production, quantification, and storage of virus-like particles.

Debbink K, Costantini V, Swanstrom J, Agnihothram S, Vinjé J, Baric R, Lindesmith L.

Curr Protoc Microbiol. 2013 Nov 5;31:15K.1.1-15K.1.45. doi: 10.1002/9780471729259.mc15k01s31.

23.

Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity.

Debbink K, Lindesmith LC, Donaldson EF, Costantini V, Beltramello M, Corti D, Swanstrom J, Lanzavecchia A, Vinjé J, Baric RS.

J Infect Dis. 2013 Dec 1;208(11):1877-87. doi: 10.1093/infdis/jit370. Epub 2013 Aug 1.

24.

Emergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.

Lindesmith LC, Costantini V, Swanstrom J, Debbink K, Donaldson EF, Vinjé J, Baric RS.

J Virol. 2013 Mar;87(5):2803-13. doi: 10.1128/JVI.03106-12. Epub 2012 Dec 26.

25.

Norovirus immunity and the great escape.

Debbink K, Lindesmith LC, Donaldson EF, Baric RS.

PLoS Pathog. 2012;8(10):e1002921. doi: 10.1371/journal.ppat.1002921. Epub 2012 Oct 18. No abstract available.

26.

Immunogenetic mechanisms driving norovirus GII.4 antigenic variation.

Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, Lanzavecchia A, Baric RS.

PLoS Pathog. 2012;8(5):e1002705. doi: 10.1371/journal.ppat.1002705. Epub 2012 May 17.

27.

Genetic mapping of a highly variable norovirus GII.4 blockade epitope: potential role in escape from human herd immunity.

Debbink K, Donaldson EF, Lindesmith LC, Baric RS.

J Virol. 2012 Jan;86(2):1214-26. doi: 10.1128/JVI.06189-11. Epub 2011 Nov 16.

28.

Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002.

Lindesmith LC, Debbink K, Swanstrom J, Vinjé J, Costantini V, Baric RS, Donaldson EF.

J Virol. 2012 Jan;86(2):873-83. doi: 10.1128/JVI.06200-11. Epub 2011 Nov 16.

29.

Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer.

Pulicherla N, Shen S, Yadav S, Debbink K, Govindasamy L, Agbandje-McKenna M, Asokan A.

Mol Ther. 2011 Jun;19(6):1070-8. doi: 10.1038/mt.2011.22. Epub 2011 Mar 1.

Supplemental Content

Loading ...
Support Center